TNF and brain neoplasm: Interestingly, recombinant TNF-alpha reduces cell viability of ZIKV-infected brain tumour cells, suggesting that in the context of oZIKV therapy, TNF-alpha is anti-tumoural as it enhances brain tumour cell oncolysis by ZIKV.